| |
|
|
|
-, Sheraton San Diego Hotel & Marina, San Diego, CA
February 23-24, 2004
Developing process validation strategies and procedures, while adhering to GMP and other regulatory guidances in a cost-effective manner, is vital to the manufacture of biologicals. In its 6th year, IBC’s Process Validation for Biologicals provides you with the information you need to develop a process validation plan that keeps your company compliant. Make the most of your time in San Diego – take advantage of a special post-conference mini-symposium to hear important updates on comparability protocols. For full conference details and to register for IBC’s Process Validation for Biologicals, go to www.LifeSciencesInfo.com/process. IBC’s Process Validation for Biologicals is conveniently held concurrently with IBC’s Inaugural Conference on 21 CFR Part 11: Ensuring Compliance and Mitigating Risk. Also, consider staying for IBC’s 12th International Conference on Antibody Production and Downstream Processing, February 25-27, 2004 and take advantage of special savings. For more information about these events, visit www.LifeSciencesInfo.com.
|
|
|
|
|
|
|
|
Organized by:
|
|
IBC Life Sciences |
|
|
Invited Speakers:
|
|
Scientific Advisors: Gail Sofer, M.S., Director of Regulatory Services, BioReliance Corporation Yuan Xu, Ph.D., Head of Worldwide Biopharmaceutical Process Development, GlaxoSmithKline
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
-
|
|
|
|
|
|
|
|
Registration:
|
|
Online: www.LifeSciencesInfo.com/process
Phone: (508) 616-5550 x1004
Fax: (508) 616-5522
E-mail: reg@ibcusa.com
|
|
|
E-mail:
|
|
reg@ibcusa.com
|
|
|
|
|
|
|
|
|